title: Strategies for the preclinical and clinical characterization of immunogenicity.
authors.affiliation: Department of Clinical Immunology, Amgen Inc, Thousand Oaks, California 91320, USA. ekoren@amgen.com
authors.forename: E
authors.initials: E
authors.lastname: Koren
authors.forename: D
authors.initials: D
authors.lastname: Mytych
authors.forename: M
authors.initials: M
authors.lastname: Koscec
authors.forename: J
authors.initials: J
authors.lastname: Ferbas
authors.forename: S
authors.initials: S
authors.lastname: Gupta
authors.forename: M
authors.initials: M
authors.lastname: Moxness
authors.forename: S
authors.initials: S
authors.lastname: Swanson
mesh_terms: D000818:Animals; D001688:Biological Products / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D004341:Drug Evaluation / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D008252:Macaca fascicularis; D011506:Proteins / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D051381:Rats
chemical_list: D001688:Biological Products; D011506:Proteins